Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
IDEXX Laboratories Oy
OY
Active
Y-tunnus 2432051-9
Hämeenkatu 26A, 33200
Tampere
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 14 years old
— employees
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
IDEXX Laboratories Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
20M
15M
10M
5M
0M
2021: 9M
9M
2021
2022: 10M (+11% vs 2021)
10M
+11%
2022
2023: 12M (+20% vs 2022)
12M
+20%
2023
2024: 15M (+25% vs 2023)
15M
+25%
2024
2025: 16M (+7% vs 2024)
16M
+7%
2025
EBITDA
EUR millions
2M
2M
1M
1M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
15 959
14 536
11 515
9 802
9 379
Staff expenses
−2 894
−2 734
−1 675
−1 133
−832
EBITDA
1 544
1 769
755
575
536
Depreciation & amort.
−1 249
−1 259
−477
−79
−74
EBIT
295
510
277
495
462
Net financials
−265
−559
−327
−77
−6
Profit before tax
31
−49
−50
418
456
Tax
189
218
74
92
103
Net profit
−158
−267
−124
326
353
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
12 723
12 710
13 830
13 451
13 840
Equity
2 541
2 699
2 966
3 090
2 764
Long-term debt
15
0
0
78
1 301
Short-term debt
10 167
10 011
10 864
10 283
9 775
Total debt
10 182
10 011
10 864
10 361
11 077
Financial ratios
5-year trend
EBITDA margin
9,7 %
This company
15,8 %
Market median
This company
Market median
39% below market
2021
2025
Equity ratio
20,0 %
This company
38,2 %
Market median
This company
Market median
48% below market
2021
2025
Return on equity
−6,2 %
This company
18,4 %
Market median
This company
Market median
134% below market
2021
2025
Net profit margin
−1,0 %
This company
8,1 %
Market median
This company
Market median
112% below market
2021
2025
Asset turnover
1,25×
This company
1,12×
Market median
This company
Market median
12% above market
2021
2025
Debt / equity
4,01×
This company
0,62×
Market median
This company
Market median
547% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on IDEXX Laboratories Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
